Funding
Supported by Regeneron Pharmaceuticals, Inc., F. Hoffmann–La Roche, and the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (contract number HHSO100201700020C).